Bioprocessing

Bioprocessing uses a complete living cell, or their components, to obtain or create a desired pharmaceutical product. Recent scientific advancements have led to biopharmaceuticals being the fastest growing drug type, leading to rapid process and equipment advances. Below you can explore editorial articles, webinars, informational resources, and products curated to keep you up to date with bioprocessing advancements.

An Interview with Lamin Jallow
The main difference is the level of detail in the new USP 73. As a chapter with a two-digit number, it contains some methodology and details that were missing in the original publication. For instance, it contains an equation to calculate the incubation time before ATP bioluminescence detection is performed. read more
An Interview with Marc Studer
Samsung Biologics has continuously invested in its capabilities to address the evolving needs of the biopharmaceutical industry. With numerous large pharmaceutical companies and emerging biotech firms introducing ADC programs given its promising therapeutic potential, the company has strategically expanded into ADC development and manufacturing to ... read more
The Bioprocess Revolution: How Technology and Trends are Reshaping Pharmaceutical Manufacturing
The pharmaceutical bioprocess equipment and services market is undergoing a profound transformation, driven by technological advancements, increasing demand for biologics, and a shift towards more effi cient and fl exible manufacturing processes. read more

Executive Q&A: Samsung Biologics
Samsung Biologics continues to introduce new and innovative technology platforms with high-performing solutions that enhance therapeutic efficacy and proactively address evolving industry trends. read more
App Note: To GMP or not to GMP? That is the (PLASMID) question
As drug manufacturers work to secure plasmids for discovery, clinical, and commercial applications, the question looms: how can you maintain a manageable budget while procuring a high- quality plasmid supply? Though opting to begin with a GMP-grade plasmid platform – as opposed to GMP-lite – may initially seem the more ... read more
Evolving the Future of Cell Therapy Manufacturing: CTS DynaCellect Magnetic Separation System
Download this brochure to learn more about the CTS DynaCellect Magnetic Separation System, that will enable you to scale your process from research to clinical manufacturing without sacrificing cell viability. read more
How SGS Supports Cell & Gene Therapy Manufacturing
Download this infographic for more information on how SGS supports C> manufacturing. read more
eBook: An Introduction to Organ-on-a-Chip Technology
This guide is for scientists who are interested in learning how next-generation Organ-on-a-Chip technology can improve their disease research and drug development programs to increase efficiency and bring more life-saving treatments to market. read more

On-Demand Webinar: Rapid Sterility Testing as the Critical and Final Result for Product Release
In this webinar, hear from Eric Chenelle, Product Manager from Rapid Micro, as he discusses Rapid Sterility Testing as the Critical and Final Result for Product Release. read more
Considerations for Expanding Cell and Gene Therapy Cultures in Bioreactors
Learn about critical industry issues that affect the development of cell and gene therapies, including key factors within bioreactors that affect cell growth and viability of cell and gene therapy cultures. read more